NON-SMALL CELL EA5181
Study #EA5181Randomized Phase III Trial of MEDI4736 (durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresected Stage 3 NSCLC
Back To Clinical Trials NCI Database Entry
Randomized Phase III Trial of MEDI4736 (durvalumab) as Concurrent and Consolidative Therapy or Consolidative Therapy Alone for Unresected Stage 3 NSCLC
Back To Clinical Trials NCI Database Entry